People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The task force determines which preventive services insurers must cover at no cost to patients.

Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

Cross River State government is exploring cost-effective local manufacturing options for production of antiretroviral (ARV) ...

The department lost $1.3 million in crucial funding as the Trump administration cuts government money for HIV research, ...

The Trump administration has eliminated some grants aimed at HIV education and prevention and cut funding at the Centers for ...

MEMPHIS, Tenn — The University of Tennessee Health and Science Center will reportedly receive a grant to research treatments ...